Pub. Date : 2010 Nov
PMID : 21317459
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapy. | Dactinomycin | tumor protein p53 | Homo sapiens |
| 2 | Here we sought to evaluate whether low doses of Actinomycin D (LDActD), a clinically-approved drug and potent p53 activator, could substitute Nutlin-3 in p53-based cyclotherapy. | Dactinomycin | tumor protein p53 | Homo sapiens |
| 3 | Here we sought to evaluate whether low doses of Actinomycin D (LDActD), a clinically-approved drug and potent p53 activator, could substitute Nutlin-3 in p53-based cyclotherapy. | Dactinomycin | tumor protein p53 | Homo sapiens |